|
Meir A. Lewittes is an associate in the law firm of McDermott Will & Emery LLP based in the Firm’s New York office. Meir is a member of the Firm’s Corporate Department, where his practice concentrates on Private Equity, Mergers and Acquisitions and Securities with a recent focus on cross-border transactions, private placements, PIPEs, joint ventures, compliance with federal securities laws and general corporate matters.
While at New York University School of Law, Meir served as an Article and Note Editor of the Journal of Legislation and Public Policy.
Representative Experience:
Represented a multi-billion dollar alternative investment fund as an investor in preferred stock and convertible notes PIPE transactions.
Represented a European specialty chemicals company in the $150 million sale of a Canadian pharmaceutical ingredient manufacturer.
Represented DaVita Inc. in its $3.05 billion acquisition of Gambro Heathcare, Inc., the US kidney dialysis business of Gambro AB.
Represented Computershare Ltd. in its acquisition of Equiserve, Inc. from DST Systems, Inc.
Represented NationsHealth, Inc., a healthcare services provider listed on Nasdaq, in a PIPE transaction raising private capital from investments funds in exchange for convertible notes.
Meir is admitted to practice in New York and is proficient in Portuguese and Hebrew.
Education:
New York University School of Law, J.D., 2002
University of Maryland, B.A., 1997 | 